Valo Health’s $300 Million Million Series B Funding Round

Goodwin Procter LLP advised Valo Health on the deal.Valo Health announced the final closing of its Series B at $300 million, including a $110 million investment…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now